CRT 2017 : FDA Town Hall - Evaluating DES for High-Risk DAPT Patients

Conference

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$6.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Overview

FDA Town Hall - Evaluating DES for High-Risk DAPT Patients

Featuring

  • Michael John
  • Davide Capodanno
  • Hans-Peter Stoll

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$6.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Moment Components

Adjunctive DAPT Labeling for DES – An FDA View - Michael John
Short versus Long DAPT Studies – An Academic View - Davide Capodanno
Study Designs of Short DAPT in the USA – Challenges and Execution of Pivotal Trials - Hans-Peter Stoll

Target Audience

Learning Objectives

Related Moments

Aorta Masterclass 2017: Session 5 - Emerging Technologies: Pipeline Session
Course
The Role of Optical Coherence Tomography in the Bioresorbable Vascular Scaffold Era
Journal
Article on The Role of Optical Coherence Tomography in the Bioresorbable Vascular Scaffold Era
Advanced Physiology Course (LYON) - Module 2
Course
1 day course, September 28th 2018 Lyon
Supported By
Loading Simple Education